Cyclooxygenase in normal human tissues – is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?
Corresponding Author
Nina Zidar
Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Correspondence to: Nina ZIDAR, Institute of Pathology, Medical Faculty, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.Tel.: +386-1-543-71 49Fax: +386-1-543-7101E-mail: [email protected]Search for more papers by this authorKatarina Odar
Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Search for more papers by this authorDamjan Glavac
Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Search for more papers by this authorMaja Jerse
Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Search for more papers by this authorTomaz Zupanc
Institute of Forensic Medicine, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Search for more papers by this authorDusan Stajer
Centre for Intensive Internal Medicine, University Medical Centre, Ljubljana, Slovenia
Search for more papers by this authorCorresponding Author
Nina Zidar
Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Correspondence to: Nina ZIDAR, Institute of Pathology, Medical Faculty, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.Tel.: +386-1-543-71 49Fax: +386-1-543-7101E-mail: [email protected]Search for more papers by this authorKatarina Odar
Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Search for more papers by this authorDamjan Glavac
Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Search for more papers by this authorMaja Jerse
Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Search for more papers by this authorTomaz Zupanc
Institute of Forensic Medicine, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Search for more papers by this authorDusan Stajer
Centre for Intensive Internal Medicine, University Medical Centre, Ljubljana, Slovenia
Search for more papers by this authorAbstract
Cyclooxygenase (COX) is a key enzyme in prostanoid synthesis. It exists in two isoforms, COX-1 and COX-2. COX-1 is referred to as a ‘constitutive isoform’, and is considered to be expressed in most tissues under basal conditions. In contrast, COX-2 is referred to as an ‘inducible isoform’, which is believed to be undetectable in most normal tissues, but can be up-regulated during various conditions, many of them pathological. Even though the role of COX in homeostasis and disease in now well appreciated, controversial information is available concerning the distribution of COX isoforms in normal human tissues. There is mounting evidence that it is much more complex than generally believed. Our aim was therefore to analyse the expression and distribution of COX isoforms in normal human tissues, using immunohistochemistry, Western blotting and real-time RT-PCR. Autopsy samples from 20 healthy trauma victims and samples from 48 biopsy surgical specimens were included. COX-1 was found in blood vessels, interstitial cells, smooth muscle cells, platelets and mesothelial cells. In contrast, COX-2 was found predominantly in the parenchymal cells of many tissues, with few exceptions, for example the heart. Our results confirm the hypothesis that the distribution of COX isoforms in healthy tissues is much more complex than generally believed. This and previous studies indicate that both isoforms, not only COX-1, are present in many normal human tissues, and that both isoforms, not only COX-2, are up-regulated in various pathological conditions. We may have to revise the concept of ‘constitutive’ and ‘inducible’ COX isoforms.
References
- 1 Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev. 2004; 56: 387–437.
- 2 Anderson WF, Umar A, Viner JL, et al . The role of cyclooxygenase inhibitors in cancer prevention. Curr Pharm Des. 2002; 8: 1035–62.
- 3 Seibert K, Masferrer JL. Role of inducible cyclooxygenase (COX-2) in inflammation. Receptor. 1994; 4: 17–23.
- 4 Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998; 38: 97–120.
- 5 Cippolone F, Fazia ML. COX-2 and atherosclerosis. J Cardiovasc Pharmacol. 2006; 47: S26–36.
- 6 Yermakova A, O’Banion MK. Cyclooxygenases in the central nervous system: implications for treatment of neurological disorders. Curr Pharm Des. 2000; 6: 1755–76.
- 7 Martel-Pelletier J, Pelletier JP, Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum. 2003; 33: 155–67.
- 8 Smith WL, Garavito RM, De Witt DL. Prostaglandin-endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem. 1996; 271: 33157–60.
- 9 O’Neill GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 1993; 330: 156–60.
- 10 Langenbach R, Loftin C, Lee C, et al . Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. Biochem Pharmacol. 1999; 58: 1237–46.
- 11 Yasojima K, Schwab C, McGeer EG, et al . Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs. Brain Res. 1999; 830: 226–36.
- 12 Rioux N, Castonguay A. The induction of cyclooxygenase-1 by a tobacco carcinogen in U937 human macrophages is correlated to the activation of NF-kappaB. Carcinogenesis. 2000; 21: 1745–51.
- 13 Harris RC, Breyer MD. Update on cyclooxygenase-2 inhibitors. Clin J Am Soc Nephrol. 2006; 1: 236–45.
- 14 Zidar N, Dolenc-Strazar Z, Jeruc J, et al . Expression of cyclooxygenase-1 and cyclooxygenase-2 in the normal human heart and in myocardial infarction. Cardiovasc Pathol. 2007; 16: 300–4.
- 15 Sanoudou D, Kang PB, Haslett JN, et al . Transcriptional profile of postmortem skeletal muscle. Physiol Genomics. 2004; 16: 222–8.
- 16 Livak KJ, Thomas DS. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001; 25: 402–8.
- 17 Sano H, Kawahito Y, Wilder RL, et al . Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Research. 1995; 55: 3785–9.
- 18 Komhoff M, Grone HJ, Klein T, et al . Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol. 1997; 272: F460–8.
- 19 Zimmermann KC, Sarbia M, Schror K, et al . Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa. Mol Pharmacol. 1998; 54: 536–40.
- 20 Smith TJ, Jennings TA, Sciaky D, et al . Prostaglandin-endoperoxide synthase-2 expression in human thyroid epithelium. Evidence for constitutive expressionin vivo and in cultured KAT-50 cells. J Biol Chem. 1999; 274: 15622–32.
- 21 Kirschenbaum A, Klausner AP, Lee R, et al . Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. Urology. 2000; 56: 671–6.
- 22 Kirschenbaum A, Liotta DR, Yao S, et al . Immunohistochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the human fetal and adult male reproductive tracts. J Clin Endocrinol Metab. 2000; 85: 3436–41.
- 23 Jackson LM, Wu KC, Mahida YR, et al . Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa. Gut. 2000; 47: 762–70.
- 24 Chariyalertsak S, Sirikulchayanonta V, Mayer D, et al . Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma. Gut. 2001; 48: 80–6.
- 25 Stavreus-Evers A, Koraen L, Scott JE, et al . Distribution of cyclooxygenase-1, cyclooxygenase-2, and cytosolic phospholipase A2 in the luteal phase human endometrium and ovary. Fertil Steril. 2005; 83: 156–62.
- 26 Fornai M, Blandizzi C, Colucci R, et al . Role of cyclooxygenase 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice. Gut. 2005; 54: 608–16.
- 27 Takano T, Tian GF, Peng W, et al . Astrocyte-mediated control of cerebral blood flow. Nat Neurosci. 2006; 9: 260–7.
- 28 Asano K, Lilly CM, Drazen JM. Prostaglandin G/H synthase-2 is the constitutive and dominant isoform in cultured human lung epithelial cells. Am J Physiol. 1996; 271: L126–31.
- 29 Koki A, Khan NK, Woerner M, et al . Cyclooxygenase-2 in human pathological disease. Adv Exp Med Biol. 2002; 507: 177–84.
- 30 Kuiper J, Zijlstra FJ, Kamps JA, et al . Cellular communication inside the liver. Binding, conversion and metabolic effect of prostaglandin D2 on parenchymal liver cells. Biochem J. 1989; 262: 195–201.
- 31 Mitchell JA, Lucas R, Vojnovic I, et al . Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events. FASEB J. 2006; 20: 2468–75.
- 32 Uchida K, Kamikawa Y. Muscularis mucosae – the forgotten sibling. J Smooth Muscle Res. 2007; 43: 157–77.
- 33 Harris RC, Breyer MD. Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol. 2001; 281: F1–11.
- 34 Sirois J, Sayasith K, Brown KA, et al . Cyclooxygenase-2 and its role in ovulation: a 2004 account. Human Reproduction Update. 2006; 17: 373–85.
- 35 Ermert L, Ermert M, Goppelt-Struebe M, et al . Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am J Respir Cell Mol Biol. 1998; 18: 479–88.
- 36 Hida T, Yatabe Y, Achiwa H, et al . Increased expression of cyclooxygenase2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Research. 1998; 58: 3761–4.
- 37 McKanna JA, Zhang MZ, Wang JL, et al . Constitutive expression of cyclooxygenase-2 in rat vas deferens. Am J Physiol. 1998; 275: R227–33.
- 38 Robertson RP. Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis. Diabetes. 1998; 47: 1379–83.
- 39 Salmenkivi K, Haglund C, Ristimaki A, et al . Increased expression of cyclooxygenase-2 in malignant pheochromocytomas. J Clin Endocrinol Metab. 2001; 86: 5615–9.
- 40 Bloomer CW, Kenyon L, Hammond E, et al . Cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR) expression in human pituitary macroadenomas. Am J Clin Oncol. 2003; 26: S75–80.
- 41 Bernardini N, Colucci R, Mattii L, et al . Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon. Neurogastroenterol Motil. 2006; 18: 654–62.
- 42 Winnall WR, Ali U, O’Bryan MK, et al . Constitutive expression of prostaglandin-endoperoxide synthase 2 by somatic and spermatogenic cells is responsible for prostaglandin E2 production in the adult rat testis. Biol Reprod. 2007; 76: 759–68.
- 43 Kim JW, Baek BS, Kim YK, et al . Gene expression of cyclooxygenase in the aging heart. J Gerontol A Biol Sci Med Sci. 2001; 56: B350–5.
- 44 Abbate A, Santini D, Biondi-Zoccai GG, et al . Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe Heart. 2004; 90: 440–3.
- 45 LaPointe MC, Mendez M, Leung A, et al . Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse. Am J Physiol Heart Circ Physiol. 2004; 286: H1416–24.
- 46 Mungan MU, Gurel D, Canda AE, et al . Expression of COX-2 in normal and pyelonephritic kidney, renal intraepithelial neoplasia, and renal cell carcinoma. Eur Urol. 2006; 50: 92–7.
- 47 Sakurai M, Oishi K, Watanabe K. Localization of cyclooxygenases-1 and -2, and prostaglandin F synthase in human kidney and renal cell carcinoma. Biochem Biophys Res Commun. 2005; 338: 82–6.
- 48 Khan KN, Venturini CM, Bunch RT, et al . Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity. Toxicol Pathol. 1998; 26: 612–20.
- 49 Garewal H, Ramsey L, Fass R, et al . Perils of immunohistochemistry: variability in staining specificity of commercially available COX-2 antibodies on human colon tissue. Dig Dis Sci. 2003; 48: 197–202.
- 50 Sarkar P, Hayes BE. Induction of COX-2 by acrolein in rat lung epithelial cells. Mol Cell Biochem. 2007; 301: 191–9.
- 51 Knapp DJ, Crews FT. Induction of cyclooxygenase-2 in brain during acute and chronic ethanol treatment and ethanol withdrawal. Alcohol Clin Exp Res. 1999; 23: 633–43.
- 52 Hsueh SF, Lu CY, Chao CS, et al . Nonsteroidal anti-inflammatory drugs increase expression of inducible COX-2 isoform of cyclooxygenase in spinal cord of rats with adjuvant induced inflammation. Brain Res Mol Brain Res. 2004; 125: 113–9.
- 53 Dixon DA, Kaplan CD, McIntyre TM, et al . Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3’-untranslated region. J Biol Chem. 2000; 275: 11750–7.
- 54 Sevigny MB, Li CF, Alas M, et al . Glycosylation regulates turnover of cyclooxygenase-2. FEBS Lett. 2006; 580: 6533–6.